Merlo E, Freudenthal R, Romano A (2002). The IkappaB kinase inhibitor sulfasalazine impairs long-term memory in the crab Chasmagnathus. Neuroscience112 (1): 161–172. PMID12044481. DOI: 10.1016/S0306-4522(02)00049-0.
Park HJ, Youn HS (March 2013). Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase. Toxicology and Industrial Health29 (2): 169–174. PMID22080037. DOI: 10.1177/0748233711427048.
Biancalana M, Natan E, Lenardo MJ, Fersht AR (September 2021). NF-κB Rel subunit exchange on a physiological timescale. Protein Science30 (9): 1818–1832. PMID34089216. PMC8376415. DOI: 10.1002/pro.4134.
Waterhouse RM, Kriventseva EV, Meister S, Xi Z, Alvarez KS, Bartholomay LC, Barillas-Mury C, Bian G, Blandin S, Christensen BM, Dong Y, Jiang H, Kanost MR, Koutsos AC, Levashina EA, Li J, Ligoxygakis P, Maccallum RM, Mayhew GF, Mendes A, Michel K, Osta MA, Paskewitz S, Shin SW, Vlachou D, Wang L, Wei W, Zheng L, Zou Z, Severson DW, Raikhel AS, Kafatos FC, Dimopoulos G, Zdobnov EM, Christophides GK (June 2007). Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes. Science316 (5832): 1738–1743. PMID17588928. PMC2042107. DOI: 10.1126/science.1139862.
3do7; Fusco AJ, Huang DB, Miller D, Wang VY, Vu D, Ghosh G (February 2009). NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes. EMBO Reports10 (2): 152–159. PMID19098713. PMC2637311. DOI: 10.1038/embor.2008.227.
Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, Dean K, Franzoso G (May 2006). The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death and Differentiation13 (5): 712–729. PMID16456579. DOI: 10.1038/sj.cdd.4401865.
Doyle SL, O'Neill LA (October 2006). Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochemical Pharmacology72 (9): 1102–1113. PMID16930560. DOI: 10.1016/j.bcp.2006.07.010.
Hayden MS, West AP, Ghosh S (October 2006). NF-kappaB and the immune response. Oncogene25 (51): 6758–6780. PMID17072327. DOI: 10.1038/sj.onc.1209943.
Li Q, Verma IM (October 2002). NF-kappaB regulation in the immune system. Nature Reviews. Immunology2 (10): 725–734. PMID12360211. DOI: 10.1038/nri910.
Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U (March 1993). The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell72 (5): 729–739. PMID8453667. DOI: 10.1016/0092-8674(93)90401-B.
Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, Hoffmann A (January 2007). A fourth IkappaB protein within the NF-kappaB signaling module. Cell128 (2): 369–381. PMID17254973. PMC1831796. DOI: 10.1016/j.cell.2006.12.033. .
Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, White MR (October 2004). Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science306 (5696): 704–708. PMID15499023. DOI: 10.1126/science.1099962.
Adkins I, Schulz S, Borgmann S, Autenrieth IB, Gröbner S (February 2008). Differential roles of Yersinia outer protein P-mediated inhibition of nuclear factor-kappa B in the induction of cell death in dendritic cells and macrophages. Journal of Medical Microbiology57 (Pt 2): 139–144. PMID18201977. DOI: 10.1099/jmm.0.47437-0.
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (June 2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. The EMBO Journal23 (12): 2369–2380. PMID15152190. PMC423286. DOI: 10.1038/sj.emboj.7600244.
Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M (October 2004). Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. The EMBO Journal23 (21): 4202–4210. PMID15470505. PMC524385. DOI: 10.1038/sj.emboj.7600391.
Mukherjee T, Chatterjee B, Dhar A, Bais SS, Chawla M, Roy P, George A, Bal V, Rath S, Basak S (December 2017). A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs. The EMBO Journal36 (23): 3501–3516. PMID29061763. PMC5709727. DOI: 10.15252/embj.201796919.
Roy P, Mukherjee T, Chatterjee B, Vijayaragavan B, Banoth B, Basak S (March 2017). Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. Oncogene36 (10): 1417–1429. PMID27641334. PMC5346295. DOI: 10.1038/onc.2016.309.
Smith EM, Gregg M, Hashemi F, Schott L, Hughes TK (1 juli 2006). Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes. Cellular and Molecular Neurobiology26 (4–6): 1021–1036. PMID16633893. DOI: 10.1007/s10571-006-9040-1.
Livolsi A, Busuttil V, Imbert V, Abraham RT, Peyron JF (March 2001). Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. European Journal of Biochemistry268 (5): 1508–1515. PMID11231305. DOI: 10.1046/j.1432-1327.2001.02028.x.
Mattson MP, Meffert MK (May 2006). Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death and Differentiation13 (5): 852–860. PMID16397579. DOI: 10.1038/sj.cdd.4401837.
Heckscher ES, Fetter RD, Marek KW, Albin SD, Davis GW (September 2007). NF-kappaB, IkappaB, and IRAK control glutamate receptor density at the Drosophila NMJ. Neuron55 (6): 859–873. PMID17880891. PMC2701504. DOI: 10.1016/j.neuron.2007.08.005.
Wang J, Fu XQ, Lei WL, Wang T, Sheng AL, Luo ZG (August 2010). Nuclear factor kappaB controls acetylcholine receptor clustering at the neuromuscular junction. The Journal of Neuroscience30 (33): 11104–11113. PMID20720118. PMC6633475. DOI: 10.1523/JNEUROSCI.2118-10.2010.
Boersma MC, Dresselhaus EC, De Biase LM, Mihalas AB, Bergles DE, Meffert MK (April 2011). A requirement for nuclear factor-kappaB in developmental and plasticity-associated synaptogenesis. The Journal of Neuroscience31 (14): 5414–5425. PMID21471377. PMC3113725. DOI: 10.1523/JNEUROSCI.2456-10.2011.
Gutierrez H, Hale VA, Dolcet X, Davies A (April 2005). NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development132 (7): 1713–1726. PMID15743881. DOI: 10.1242/dev.01702.
Zaheer A, Yorek MA, Lim R (December 2001). Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochemical Research26 (12): 1293–1299. PMID11885780. DOI: 10.1023/A:1014241300179.
Qiu J, Hu X, Nesic O, Grafe MR, Rassin DK, Wood TG, Perez-Polo JR (July 2004). Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia. Journal of Neuroscience Research77 (1): 108–118. PMID15197744. DOI: 10.1002/jnr.20156.
Jarosinski KW, Whitney LW, Massa PT (September 2001). Specific deficiency in nuclear factor-kappaB activation in neurons of the central nervous system. Laboratory Investigation; A Journal of Technical Methods and Pathology81 (9): 1275–1288. PMID11555675. DOI: 10.1038/labinvest.3780341.
Herkenham M, Rathore P, Brown P, Listwak SJ (October 2011). Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies. Journal of Neuroinflammation8: 141. PMID21999414. PMC3210105. DOI: 10.1186/1742-2094-8-141.
Moerman AM, Mao X, Lucas MM, Barger SW (April 1999). Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB. Brain Research. Molecular Brain Research67 (2): 303–315. PMID10216229. DOI: 10.1016/s0169-328x(99)00091-1.
Mao XR, Moerman-Herzog AM, Chen Y, Barger SW (May 2009). Unique aspects of transcriptional regulation in neurons--nuances in NFkappaB and Sp1-related factors. Journal of Neuroinflammation6: 16. PMID19450264. PMC2693111. DOI: 10.1186/1742-2094-6-16.
Mao X, Yang SH, Simpkins JW, Barger SW (March 2007). Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. Journal of Neurochemistry100 (5): 1300–1314. PMID17316402. PMC1949346. DOI: 10.1111/j.1471-4159.2006.04297.x.
Vlahopoulos SA (August 2017). Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode. Cancer Biology & Medicine14 (3): 254–270. PMID28884042. PMC5570602. DOI: 10.20892/j.issn.2095-3941.2017.0029.
Vlahopoulos SA, Cen O, Hengen N, Agan J, Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA, Boldogh I, Karin M, Chrousos GP (August 2015). Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment. Cytokine & Growth Factor Reviews26 (4): 389–403. PMID26119834. PMC4526340. DOI: 10.1016/j.cytogfr.2015.06.001.
Sheikh MS, Huang Y (2003). Death receptor activation complexes: it takes two to activate TNF receptor 1. Cell Cycle2 (6): 550–552. PMID14504472. DOI: 10.4161/cc.2.6.566.
Li YY, Chung GT, Lui VW, To KF, Ma BB, Chow C, Woo JK, Yip KY, Seo J, Hui EP, Mak MK, Rusan M, Chau NG, Or YY, Law MH, Law PP, Liu ZW, Ngan HL, Hau PM, Verhoeft KR, Poon PH, Yoo SK, Shin JY, Lee SD, Lun SW, Jia L, Chan AW, Chan JY, Lai PB, Fung CY, Hung ST, Wang L, Chang AM, Chiosea SI, Hedberg ML, Tsao SW, van Hasselt AC, Chan AT, Grandis JR, Hammerman PS, Lo KW (January 2017). Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. Nature Communications8: 14121. PMID28098136. PMC5253631. DOI: 10.1038/ncomms14121.
Nouri M, Massah S, Caradec J, Lubik AA, Li N, Truong S, Lee AR, Fazli L, Ramnarine VR, Lovnicki JM, Moore J, Wang M, Foo J, Gleave ME, Hollier BG, Nelson C, Collins C, Dong X, Buttyan R (April 2020). Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer. Clinical Cancer Research26 (7): 1678–1689. PMID31919137. DOI: 10.1158/1078-0432.CCR-19-0098.
(May 2018). NF-κB, inflammation, immunity and cancer: coming of age. Nature Reviews. Immunology18 (5): 309–324. PMID29379212. DOI: 10.1038/nri.2017.142.
Sun L, Mathews LA, Cabarcas SM, Zhang X, Yang A, Zhang Y, Young MR, Klarmann KD, Keller JR, Farrar WL (August 2013). Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells31 (8): 1454–1466. PMID23592398. PMC3775871. DOI: 10.1002/stem.1394.
Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A (March 2007). The transcription factor nuclear factor-kappa B and cancer. Clinical Oncology19 (2): 154–161. PMID17355113. DOI: 10.1016/j.clon.2006.11.013.
Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, Cheshire N, Paleolog E, Feldmann M (April 2004). Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America101 (15): 5634–5639. PMID15064395. PMC397455. DOI: 10.1073/pnas.0401060101.
Venuraju SM, Yerramasu A, Corder R, Lahiri A (May 2010). Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. Journal of the American College of Cardiology55 (19): 2049–2061. PMID20447527. DOI: 10.1016/j.jacc.2010.03.013.
Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP (March 2009). The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biological Psychiatry65 (6): 481–488. PMID19058794. DOI: 10.1016/j.biopsych.2008.10.018.
Kaisari S, Rom O, Aizenbud D, Reznick AZ (2013). Neurobiology of Respiration. DOI:10.1007/978-94-007-6627-3_2, "Involvement of NF-κB and Muscle Specific E3 Ubiquitin Ligase MuRF1 in Cigarette Smoke-Induced Catabolism in C2 Myotubes", 7–17. ISBN 978-94-007-6626-6.
Vidal PM, Lemmens E, Dooley D, Hendrix S (February 2013). The role of "anti-inflammatory" cytokines in axon regeneration. Cytokine & Growth Factor Reviews24 (1): 1–12. PMID22985997. DOI: 10.1016/j.cytogfr.2012.08.008.
Grivennikov SI, Karin M (February 2010). Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine & Growth Factor Reviews21 (1): 11–19. PMID20018552. PMC2834864. DOI: 10.1016/j.cytogfr.2009.11.005.
Bonavita E, Galdiero MR, Jaillon S, Mantovani A (2015). Phagocytes as Corrupted Policemen in Cancer-Related Inflammation. Advances in Cancer Research128: 141–171. PMID26216632. DOI: 10.1016/bs.acr.2015.04.013.
Sionov RV, Fridlender ZG, Granot Z (December 2015). The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment. Cancer Microenvironment8 (3): 125–158. PMID24895166. PMC4714999. DOI: 10.1007/s12307-014-0147-5.
Kong X, Li L, Li Z, Xie K (December 2012). Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications. Cytokine & Growth Factor Reviews23 (6): 343–356. PMID22749856. PMC3505269. DOI: 10.1016/j.cytogfr.2012.06.006.
Mecollari V, Nieuwenhuis B, Verhaagen J (2014). A perspective on the role of class III semaphorin signaling in central nervous system trauma. Frontiers in Cellular Neuroscience8: 328. PMID25386118. PMC4209881. DOI: 10.3389/fncel.2014.00328.
Merlo E, Freudenthal R, Romano A (2002). The IkappaB kinase inhibitor sulfasalazine impairs long-term memory in the crab Chasmagnathus. Neuroscience112 (1): 161–172. PMID12044481. DOI: 10.1016/S0306-4522(02)00049-0.
Park HJ, Youn HS (March 2013). Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase. Toxicology and Industrial Health29 (2): 169–174. PMID22080037. DOI: 10.1177/0748233711427048.
Biancalana M, Natan E, Lenardo MJ, Fersht AR (September 2021). NF-κB Rel subunit exchange on a physiological timescale. Protein Science30 (9): 1818–1832. PMID34089216. PMC8376415. DOI: 10.1002/pro.4134.
Waterhouse RM, Kriventseva EV, Meister S, Xi Z, Alvarez KS, Bartholomay LC, Barillas-Mury C, Bian G, Blandin S, Christensen BM, Dong Y, Jiang H, Kanost MR, Koutsos AC, Levashina EA, Li J, Ligoxygakis P, Maccallum RM, Mayhew GF, Mendes A, Michel K, Osta MA, Paskewitz S, Shin SW, Vlachou D, Wang L, Wei W, Zheng L, Zou Z, Severson DW, Raikhel AS, Kafatos FC, Dimopoulos G, Zdobnov EM, Christophides GK (June 2007). Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes. Science316 (5832): 1738–1743. PMID17588928. PMC2042107. DOI: 10.1126/science.1139862.
3do7; Fusco AJ, Huang DB, Miller D, Wang VY, Vu D, Ghosh G (February 2009). NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes. EMBO Reports10 (2): 152–159. PMID19098713. PMC2637311. DOI: 10.1038/embor.2008.227.
Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, Dean K, Franzoso G (May 2006). The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death and Differentiation13 (5): 712–729. PMID16456579. DOI: 10.1038/sj.cdd.4401865.
Doyle SL, O'Neill LA (October 2006). Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochemical Pharmacology72 (9): 1102–1113. PMID16930560. DOI: 10.1016/j.bcp.2006.07.010.
Hayden MS, West AP, Ghosh S (October 2006). NF-kappaB and the immune response. Oncogene25 (51): 6758–6780. PMID17072327. DOI: 10.1038/sj.onc.1209943.
Li Q, Verma IM (October 2002). NF-kappaB regulation in the immune system. Nature Reviews. Immunology2 (10): 725–734. PMID12360211. DOI: 10.1038/nri910.
Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U (March 1993). The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell72 (5): 729–739. PMID8453667. DOI: 10.1016/0092-8674(93)90401-B.
Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, Hoffmann A (January 2007). A fourth IkappaB protein within the NF-kappaB signaling module. Cell128 (2): 369–381. PMID17254973. PMC1831796. DOI: 10.1016/j.cell.2006.12.033. .
Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, White MR (October 2004). Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science306 (5696): 704–708. PMID15499023. DOI: 10.1126/science.1099962.
Adkins I, Schulz S, Borgmann S, Autenrieth IB, Gröbner S (February 2008). Differential roles of Yersinia outer protein P-mediated inhibition of nuclear factor-kappa B in the induction of cell death in dendritic cells and macrophages. Journal of Medical Microbiology57 (Pt 2): 139–144. PMID18201977. DOI: 10.1099/jmm.0.47437-0.
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (June 2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. The EMBO Journal23 (12): 2369–2380. PMID15152190. PMC423286. DOI: 10.1038/sj.emboj.7600244.
Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M (October 2004). Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. The EMBO Journal23 (21): 4202–4210. PMID15470505. PMC524385. DOI: 10.1038/sj.emboj.7600391.
Mukherjee T, Chatterjee B, Dhar A, Bais SS, Chawla M, Roy P, George A, Bal V, Rath S, Basak S (December 2017). A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs. The EMBO Journal36 (23): 3501–3516. PMID29061763. PMC5709727. DOI: 10.15252/embj.201796919.
Roy P, Mukherjee T, Chatterjee B, Vijayaragavan B, Banoth B, Basak S (March 2017). Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. Oncogene36 (10): 1417–1429. PMID27641334. PMC5346295. DOI: 10.1038/onc.2016.309.
Smith EM, Gregg M, Hashemi F, Schott L, Hughes TK (1 juli 2006). Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes. Cellular and Molecular Neurobiology26 (4–6): 1021–1036. PMID16633893. DOI: 10.1007/s10571-006-9040-1.
Livolsi A, Busuttil V, Imbert V, Abraham RT, Peyron JF (March 2001). Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. European Journal of Biochemistry268 (5): 1508–1515. PMID11231305. DOI: 10.1046/j.1432-1327.2001.02028.x.
Mattson MP, Meffert MK (May 2006). Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death and Differentiation13 (5): 852–860. PMID16397579. DOI: 10.1038/sj.cdd.4401837.
Heckscher ES, Fetter RD, Marek KW, Albin SD, Davis GW (September 2007). NF-kappaB, IkappaB, and IRAK control glutamate receptor density at the Drosophila NMJ. Neuron55 (6): 859–873. PMID17880891. PMC2701504. DOI: 10.1016/j.neuron.2007.08.005.
Wang J, Fu XQ, Lei WL, Wang T, Sheng AL, Luo ZG (August 2010). Nuclear factor kappaB controls acetylcholine receptor clustering at the neuromuscular junction. The Journal of Neuroscience30 (33): 11104–11113. PMID20720118. PMC6633475. DOI: 10.1523/JNEUROSCI.2118-10.2010.
Boersma MC, Dresselhaus EC, De Biase LM, Mihalas AB, Bergles DE, Meffert MK (April 2011). A requirement for nuclear factor-kappaB in developmental and plasticity-associated synaptogenesis. The Journal of Neuroscience31 (14): 5414–5425. PMID21471377. PMC3113725. DOI: 10.1523/JNEUROSCI.2456-10.2011.
Gutierrez H, Hale VA, Dolcet X, Davies A (April 2005). NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development132 (7): 1713–1726. PMID15743881. DOI: 10.1242/dev.01702.
Zaheer A, Yorek MA, Lim R (December 2001). Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochemical Research26 (12): 1293–1299. PMID11885780. DOI: 10.1023/A:1014241300179.
Qiu J, Hu X, Nesic O, Grafe MR, Rassin DK, Wood TG, Perez-Polo JR (July 2004). Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia. Journal of Neuroscience Research77 (1): 108–118. PMID15197744. DOI: 10.1002/jnr.20156.
Jarosinski KW, Whitney LW, Massa PT (September 2001). Specific deficiency in nuclear factor-kappaB activation in neurons of the central nervous system. Laboratory Investigation; A Journal of Technical Methods and Pathology81 (9): 1275–1288. PMID11555675. DOI: 10.1038/labinvest.3780341.
Herkenham M, Rathore P, Brown P, Listwak SJ (October 2011). Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies. Journal of Neuroinflammation8: 141. PMID21999414. PMC3210105. DOI: 10.1186/1742-2094-8-141.
Moerman AM, Mao X, Lucas MM, Barger SW (April 1999). Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB. Brain Research. Molecular Brain Research67 (2): 303–315. PMID10216229. DOI: 10.1016/s0169-328x(99)00091-1.
Mao XR, Moerman-Herzog AM, Chen Y, Barger SW (May 2009). Unique aspects of transcriptional regulation in neurons--nuances in NFkappaB and Sp1-related factors. Journal of Neuroinflammation6: 16. PMID19450264. PMC2693111. DOI: 10.1186/1742-2094-6-16.
Mao X, Yang SH, Simpkins JW, Barger SW (March 2007). Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. Journal of Neurochemistry100 (5): 1300–1314. PMID17316402. PMC1949346. DOI: 10.1111/j.1471-4159.2006.04297.x.
Vlahopoulos SA (August 2017). Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode. Cancer Biology & Medicine14 (3): 254–270. PMID28884042. PMC5570602. DOI: 10.20892/j.issn.2095-3941.2017.0029.
Vlahopoulos SA, Cen O, Hengen N, Agan J, Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA, Boldogh I, Karin M, Chrousos GP (August 2015). Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment. Cytokine & Growth Factor Reviews26 (4): 389–403. PMID26119834. PMC4526340. DOI: 10.1016/j.cytogfr.2015.06.001.
Sheikh MS, Huang Y (2003). Death receptor activation complexes: it takes two to activate TNF receptor 1. Cell Cycle2 (6): 550–552. PMID14504472. DOI: 10.4161/cc.2.6.566.
Li YY, Chung GT, Lui VW, To KF, Ma BB, Chow C, Woo JK, Yip KY, Seo J, Hui EP, Mak MK, Rusan M, Chau NG, Or YY, Law MH, Law PP, Liu ZW, Ngan HL, Hau PM, Verhoeft KR, Poon PH, Yoo SK, Shin JY, Lee SD, Lun SW, Jia L, Chan AW, Chan JY, Lai PB, Fung CY, Hung ST, Wang L, Chang AM, Chiosea SI, Hedberg ML, Tsao SW, van Hasselt AC, Chan AT, Grandis JR, Hammerman PS, Lo KW (January 2017). Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. Nature Communications8: 14121. PMID28098136. PMC5253631. DOI: 10.1038/ncomms14121.
Nouri M, Massah S, Caradec J, Lubik AA, Li N, Truong S, Lee AR, Fazli L, Ramnarine VR, Lovnicki JM, Moore J, Wang M, Foo J, Gleave ME, Hollier BG, Nelson C, Collins C, Dong X, Buttyan R (April 2020). Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer. Clinical Cancer Research26 (7): 1678–1689. PMID31919137. DOI: 10.1158/1078-0432.CCR-19-0098.
(May 2018). NF-κB, inflammation, immunity and cancer: coming of age. Nature Reviews. Immunology18 (5): 309–324. PMID29379212. DOI: 10.1038/nri.2017.142.
Sun L, Mathews LA, Cabarcas SM, Zhang X, Yang A, Zhang Y, Young MR, Klarmann KD, Keller JR, Farrar WL (August 2013). Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells31 (8): 1454–1466. PMID23592398. PMC3775871. DOI: 10.1002/stem.1394.
Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A (March 2007). The transcription factor nuclear factor-kappa B and cancer. Clinical Oncology19 (2): 154–161. PMID17355113. DOI: 10.1016/j.clon.2006.11.013.
Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, Cheshire N, Paleolog E, Feldmann M (April 2004). Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America101 (15): 5634–5639. PMID15064395. PMC397455. DOI: 10.1073/pnas.0401060101.
Venuraju SM, Yerramasu A, Corder R, Lahiri A (May 2010). Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. Journal of the American College of Cardiology55 (19): 2049–2061. PMID20447527. DOI: 10.1016/j.jacc.2010.03.013.
Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP (March 2009). The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biological Psychiatry65 (6): 481–488. PMID19058794. DOI: 10.1016/j.biopsych.2008.10.018.
Vidal PM, Lemmens E, Dooley D, Hendrix S (February 2013). The role of "anti-inflammatory" cytokines in axon regeneration. Cytokine & Growth Factor Reviews24 (1): 1–12. PMID22985997. DOI: 10.1016/j.cytogfr.2012.08.008.
Grivennikov SI, Karin M (February 2010). Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine & Growth Factor Reviews21 (1): 11–19. PMID20018552. PMC2834864. DOI: 10.1016/j.cytogfr.2009.11.005.
Bonavita E, Galdiero MR, Jaillon S, Mantovani A (2015). Phagocytes as Corrupted Policemen in Cancer-Related Inflammation. Advances in Cancer Research128: 141–171. PMID26216632. DOI: 10.1016/bs.acr.2015.04.013.
Sionov RV, Fridlender ZG, Granot Z (December 2015). The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment. Cancer Microenvironment8 (3): 125–158. PMID24895166. PMC4714999. DOI: 10.1007/s12307-014-0147-5.
Kong X, Li L, Li Z, Xie K (December 2012). Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications. Cytokine & Growth Factor Reviews23 (6): 343–356. PMID22749856. PMC3505269. DOI: 10.1016/j.cytogfr.2012.06.006.
Mecollari V, Nieuwenhuis B, Verhaagen J (2014). A perspective on the role of class III semaphorin signaling in central nervous system trauma. Frontiers in Cellular Neuroscience8: 328. PMID25386118. PMC4209881. DOI: 10.3389/fncel.2014.00328.
rcsb.org
3do7; Fusco AJ, Huang DB, Miller D, Wang VY, Vu D, Ghosh G (February 2009). NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes. EMBO Reports10 (2): 152–159. PMID19098713. PMC2637311. DOI: 10.1038/embor.2008.227.